Thomas Murawski
Tom Murawski is a senior consulting actuary with the Hartford office of Milliman. He joined the firm in 2009.
Experience
Tom provides consulting services to a wide variety of clients in the U.S. healthcare system, including insurance companies, stop-loss carriers, employers, provider groups, government entities, and advocacy groups.
Tom’s focus has been on advising clients in understanding the impact and strategic implications of the ACA. His experience includes pricing health benefits, estimating reserves, and projecting financial results. Tom has led projects to assist clients in these activities for many different health products, including individual plans, small and large group plans, and stop-loss products.
Tom also has significant experience with dental plan pricing for both commercial and Medicaid populations. He has been involved in studies and analyses of the impact of the ACA on dental insurance, experience analysis studies for large employers and insurers, and review of provider fee schedules.
Tom frequently presents at industry conferences and regional actuarial meetings on dental and other health benefits topics. Tom has also authored several research reports on the potential impact and implications of proposed healthcare laws and regulations. As a result of his research, Tom has met with and advised members of Congress, Congressional Budget Office leadership, and Senior White House Policy Officials on healthcare reform proposals.
Group Insurance, 8th Edition - Chapter 6 Dental Benefits in the United States.
Professional Designations
- Fellow, Society of Actuaries
- Member, American Academy of Actuaries
Education
- BA, Mathematics and Actuarial Science, University of Connecticut
Publications
Read their latest work
Article
Dental coverage in the individual market
Article
2022 Dental Actuarial Analytics PPO Network Study Overview
Article
COVID-19: Impact to dental industry stakeholders and 2020 claims experience
Article
COVID-19: Considerations for commercial health insurance rates in 2021 and beyond
Article
COVID-19: Impact to dental utilization
Article
Is your dental rating manual stale?
Article
Leveraging drug rebates for medical stop loss product innovation
Article
Introducing the SSIP: Provisions for market stabilization in the Better Care Reconciliation Act
Article
The Patient and State Stability Fund: What happens now?
Article